Biodesix Inc - Product Pipeline Analysis, 2020 Update

Summary

Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer. The company collaborates with leading researchers to develop companion diagnostics for use with therapeutic agents and work in partnership with biotechnology and pharmaceutical companies such as Aveo Oncology and Biognosys. Biodesix is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biodesix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Biodesix Inc Company Overview
Biodesix Inc Company Snapshot
Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
Biodesix Inc – Pipeline Analysis Overview
Biodesix Inc - Key Facts
Biodesix Inc - Major Products and Services
Biodesix Inc Pipeline Products by Development Stage
Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc Pipeline Products Overview
52-Gene Panel Based Companion Diagnostic
52-Gene Panel Based Companion Diagnostic Product Overview
Companion Diagnostic Test - NSCLC
Companion Diagnostic Test - NSCLC Product Overview
Droplet Digital PCR Test - COVID-19
Droplet Digital PCR Test - COVID-19 Product Overview
HRM-MS Based Companion Diagnostic Test
HRM-MS Based Companion Diagnostic Test Product Overview
Nodify XL2
Product Status
PD-L1 Blood Based Diagnostic Test
PD-L1 Blood Based Diagnostic Test Product Overview
PD-L1 Blood Based Diagnostic Test Clinical Trial
TAm-Seq NGS Lung Cancer Test
TAm-Seq NGS Lung Cancer Test Product Overview
VeriStrat - Breast Cancer
VeriStrat - Breast Cancer Product Overview
VeriStrat - Colorectal Cancer
VeriStrat - Colorectal Cancer Product Overview
Biodesix Inc - Key Competitors
Biodesix Inc - Key Employees
Biodesix Inc - Locations And Subsidiaries
Head Office
Recent Developments
Biodesix Inc, Recent Developments
Jan 30, 2020: Biodesix, Streck sign agreement to secure FDA approval for products
Nov 05, 2019: Biodesix appoints Scott Hutton as chief executive officer
Nov 04, 2019: Biodesix announces first system-wide integration of Nodify XL2 Testing for Lung Nodule Management
Oct 08, 2019: Biodesix names Dr. James Jett Chief Medical Officer
Oct 03, 2019: Biodesix secures U.S. Patent for proprietary blood specimen collection device
Sep 23, 2019: Biodesix highlights pipeline and companion diagnostic development at World CDx and RAS-Targeted Drug Discovery
Sep 18, 2019: Biodesix announces new clinical data demonstrating VeriStrat testing predicts survival in advanced NSCLC and Immunotherapy
Aug 13, 2019: Biodesix adds Dr. Robert Georgantas III to Executive Leadership Team
Aug 07, 2019: Biodesix adds Dr. Charles Watts to Board of Directors
Jul 09, 2019: Biodesix reaches agreement to deliver next-generation sequencing assay for blood-based companion diagnostic solutions in cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
Biodesix Inc Pipeline Products by Equipment Type
Biodesix Inc Pipeline Products by Indication
Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc, Key Facts
Biodesix Inc, Major Products and Services
Biodesix Inc Number of Pipeline Products by Development Stage
Biodesix Inc Pipeline Products Summary by Development Stage
Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc Ongoing Clinical Trials Summary
52-Gene Panel Based Companion Diagnostic - Product Status
52-Gene Panel Based Companion Diagnostic - Product Description
Companion Diagnostic Test - NSCLC - Product Status
Companion Diagnostic Test - NSCLC - Product Description
Droplet Digital PCR Test - COVID-19 - Product Status
Droplet Digital PCR Test - COVID-19 - Product Description
HRM-MS Based Companion Diagnostic Test - Product Status
HRM-MS Based Companion Diagnostic Test - Product Description
Product Status
Nodify XL2 - Product Description
PD-L1 Blood Based Diagnostic Test - Product Status
PD-L1 Blood Based Diagnostic Test - Product Description
PD-L1 Blood Based Diagnostic Test - Concordance of Immunohistochemistry and a New Blood-based Expression Assay for the Detection of PD-L1 in Patients Diagnosed with Non-small Cell Lung Cancer
TAm-Seq NGS Lung Cancer Test - Product Status
TAm-Seq NGS Lung Cancer Test - Product Description
VeriStrat - Breast Cancer - Product Status
VeriStrat - Breast Cancer - Product Description
VeriStrat - Colorectal Cancer - Product Status
VeriStrat - Colorectal Cancer - Product Description
Biodesix Inc, Key Employees
Glossary
List of Figures
Biodesix Inc Pipeline Products by Equipment Type
Biodesix Inc Pipeline Products by Development Stage
Biodesix Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook